Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory

Published:2023-06 Issue: Volume:162 Page:114640
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Bozzini Sara,Della Zoppa Matteo,Bagnera Cecilia,Bozza Eleonora,Croce Stefania,Valsecchi Chiara,Belliato Mirko,Pandolfi Laura,Morbini Patrizia,Comoli Patrizia,Avanzini Maria Antonietta,Meloni Federica

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference27 articles.

1. Post COVID -19 pneumonia pulmonary fibrosis;Tale;QJM,2020

2. Pulmonary fibrosis in the aftermath of the COVID-19 era;Vasarmidi;Exp. Ther. Med.,2020

3. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy;George;Lancet Respir. Med.,2020

4. Fibroblast differentiation in wound healing and fibrosis;Darby;Int Rev. Cytol.,2007

5. C.F. Hung CF, Origin of myofibroblasts in lung fibrosis, Lung Inj Fibr 1 (2020) 155–162.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis;The American Journal of Pathology;2024-07

2. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets;QJM: An International Journal of Medicine;2023-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP